Clinical Trials on Pediatric-Onset Multiple Sclerosis (POMS) in Japan
Total 32 results
-
National Center of Neurology and Psychiatry, JapanCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveJapan
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisJapan
-
Teva Takeda Pharma Ltd.Completed
-
Novartis PharmaceuticalsActive, not recruitingRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisKorea, Republic of, Taiwan, Czechia, Japan, Poland
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisJapan, Russian Federation
-
BiogenTerminated
-
Chiba UniversityCompleted
-
EMD SeronoMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdTerminatedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Japan, Poland, Russian Federation, Spain, Ukraine, Greece
-
Ono Pharma USA IncCompletedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Japan, Poland, Russian Federation, Spain, Ukraine
-
SanofiRecruitingMultiple SclerosisKorea, Republic of, United States, China, Canada, Australia, Puerto Rico, United Kingdom, Turkey, Japan
-
NovartisMitsubishi Tanabe Pharma CorporationCompleted
-
BiogenCompleted
-
NovartisMitsubishi Tanabe Pharma CorporationCompletedMultiple SclerosisJapan
-
NobelpharmaCompletedPlaque | Tuberous Sclerosis | Angiofibroma | Hypomelanotic MaculeJapan
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple Sclerosis (SPMS)Japan
-
NobelpharmaCompletedPlaque | Tuberous Sclerosis | Angiofibroma | Hypomelanotic MaculeJapan
-
SanofiRecruitingPrimary Progressive Multiple SclerosisSpain, Italy, Turkey, India, Israel, Bulgaria, Mexico, Greece, Portugal, United States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Estonia, France, Georgia, Germany, Hungary, Japan and more
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
BiogenRecruitingRelapsing Forms of Multiple SclerosisChina, Japan
-
NobelpharmaActive, not recruitingTuberous Sclerosis ComplexJapan
-
Novartis PharmaceuticalsTerminatedMultiple SclerosisBelgium, Spain, Russian Federation, France, Italy, Poland, Sweden, Turkey, Czech Republic, Japan
-
SanofiActive, not recruitingRelapsing Multiple SclerosisSpain, United States, Mexico, Japan, Austria, Belarus, Bulgaria, Canada, China, Czechia, Denmark, Estonia, Finland, Germany, Italy, Lithuania, Poland, Romania, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, Hong Kong
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Germany, Hungary, Poland, Portugal, Russian Federation, Slovakia, Spain, Denmark, France, Japan, Israel, Taiwan, Turkey, Czechia, Argentina, Estonia, United Kingdom, India, C... and more
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisChina, Germany, United States, Romania, Italy, Austria, Belgium, Czechia, Spain, Australia, Canada, France, Israel, Switzerland, Bulgaria, Hungary, Netherlands, United Kingdom, Estonia, Latvia, Lithuania, Russian Federation, Turkey, J... and more
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisUnited States, Canada, China, Spain, Italy, France, Slovenia, Japan, Turkey, Argentina, Estonia, Greece, Mexico, Poland, Sweden, Croatia, South Africa, Brazil, Slovakia, Bulgaria, Romania, India, Portugal, United Kingdom, Puerto Rico
-
SanofiRecruitingMultiple SclerosisIsrael, United States, China, Canada, Puerto Rico, United Kingdom, Chile, Turkey, Japan
-
Novartis PharmaceuticalsCompletedTuberous Sclerosis Complex-associated Refractory SeizuresUnited States, Colombia, Belgium, France, Japan, Taiwan, Turkey, Spain, Thailand, Korea, Republic of, Australia, Hungary, United Kingdom, Canada, Norway, Germany, Italy, Russian Federation, Denmark, Argentina, Netherlands, Greece, P... and more
-
Novartis PharmaceuticalsActive, not recruitingTuberous Sclerosis ComplexUnited States, Spain, Belgium, Taiwan, Turkey, Australia, Korea, Republic of, Thailand, France, Hungary, United Kingdom, Italy, Japan, Canada, Russian Federation, Poland, Mexico, Colombia
-
Novartis PharmaceuticalsCompletedLymphangioleiomyomatosis (LAM) | Tuberous Sclerosis Complex (TSC)United States, United Kingdom, Germany, Italy, Russian Federation, Netherlands, Japan, Canada, Poland, France, Spain
-
Experimental and Clinical Research Center, a cooperation...RecruitingMultiple Sclerosis | Demyelinating Diseases | Optic Neuritis | Neuromyelitis Optica Spectrum Disorder Attack | Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseItaly, United States, Argentina, Australia, Botswana, Brazil, Colombia, Denmark, France, Germany, India, Israel, Japan, Korea, Republic of, Spain, United Kingdom, Zambia